Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?
by Sarita Garza · The Markets DailyTerumo Corp. (OTCMKTS:TRUMY – Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $13.09, but opened at $12.5101. Terumo shares last traded at $12.9315, with a volume of 916,960 shares trading hands.
Terumo Stock Performance
The firm’s 50 day simple moving average is $14.65 and its 200 day simple moving average is $16.18. The firm has a market cap of $19.17 billion, a PE ratio of 21.66 and a beta of 0.75. The company has a current ratio of 2.51, a quick ratio of 1.46 and a debt-to-equity ratio of 0.07.
Terumo (OTCMKTS:TRUMY – Get Free Report) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.75 billion. Terumo had a return on equity of 9.39% and a net margin of 12.35%.
About Terumo
Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.
Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.